Effect of Guduchyadi Kwath in the Management of Ekakustha (Psoriasis)

Clinical Evaluation of Guduchyadi Kwath in the Management of Ekakustha w.s.r. to Psoriasis: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043098

Enrollment

Registered

2022-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age- Between 18- 59 years 2. Sex- Male & Female patients. 3. Patient willing to participate in clinical trial. 4. Patient having clinical signs & symptoms of Ekakustha w.s.r. to Psoriasis. 5. Patients having chronicity less than five years duration

Exclusion criteria

Exclusion criteria: 1.Age- below 18years and above 59 years. 2. Patient with long term history of steroid and cytotoxic treatment. 3. Patients having concomitant illness like uncontrolled hypertension, diabetes mellitus, HIV, malignancy etc. 4. Patients having other associated skin disease like eczema, secondary bacterial infection. 5. Patient participated in any clinical trial within last 6 months.

Design outcomes

Secondary

Measure	Time frame
1. Asvedana (loss of perspiration) 2. MahÄ?vÄ?stu / Maá¹?á¸?ala (lisions distibution) 3. MatsyaÅ?akalopama (Scaling) 4. Ká¹?á¹£á¹?a arÅ«á¹?a vará¹?a / Abhrakpatrasama (Discoloration) 5. Kaá¹?dÅ« (Itching) 6. Ruká¹£atÄ? (Dryness) changes in above parameters.Timepoint: 3 weeks	—

Primary

Measure	Time frame
Changes in Psoriasis Area and Severity Index (PASI) ScoreTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Akshay Solanki

National Institute Of Ayurveda Jaipur

akshaysolanki171997@gmail.com7698685202

Outcome results